Joseph S. Zakrzewski, Director at Cyteir Therapeutics, Inc. (CYT), bought 200 shares at $9.88 ($2K) on 2021-12-17, disclosed to the SEC on 2021-12-21.
Open-market purchase of $2k CYT by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Something here stands out, but not much.
| Filing → |
| ANTX | SELL | 2024-01-19 | $1.9M | — | Filing → |
| CYT | BUY | 2022-12-08 | $28K | — | Filing → |
| CYT | BUY | 2022-05-16 | $1K | — | Filing → |